|
Tuesday, November 14, 2017
Print Current Session:
 |
|
|
Tuesday
SESSION 9:
NEW DEVELOPMENTS IN THE MANAGEMENT OF AAAs AND EVAR
|
|
| SESSION 9 SCHEDULE | |
| 6:40 AM - 6:44 AM | Opening Remarks |
|
Presenter(s):Enrico Ascher, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:45 AM - 6:50 AM | Inflammatory AAAs Are Best Treated By EVAR Plus Immunosuppressive Drugs: What Is The Evidence |
|
Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:51 AM - 6:56 AM | DEBATE: EVAR Performed Outside Devices’ IFUs Have Worse Outcomes With High Rates Of Endoleaks And Sac Growth |
|
Presenter(s):Andres Schanzer, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:57 AM - 7:02 AM | DEBATE: Not So: With Modern Endografts And Improved Techniques EVAR Outside IFUs Can Have Good Outcomes With Low Rates Of Endoleaks And Sac Growth |
|
Presenter(s):Dittmar Boeckler, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:03 AM - 7:08 AM | DEBATE: Differences In Outcomes Of AAA Repair Between The US And The UK Support Fixing AAAs At Diameters < 5.5 cm In Men And < 5.0 cm In Women: Landmark RCTs And Guidelines Are Wrong |
|
Presenter(s):Matt M. Thompson, MD / Marc L. Schermerhorn, MD / Ian Loftus, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:09 AM - 7:14 AM | DEBATE: Nonsense: The RCTs Are Right And The Guidelines Are Fine: AAAs Should Only Be Fixed At Or Above 5.5 cm In Diameter In Men And 5.0 cm In Women – Except In Unusual Circumstances |
|
Presenter(s):Janet T. Powell, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | Panel Discussion |
| Moderator(s): Juan C. Parodi, MD / Enrico Ascher, MD | |
| 7:20 AM - 7:25 AM | Status Of The LEOPARD Trial: A RCT Comparing The AFX Endologix Graft For EVAR To Other Standard EVAR Endografts |
|
Presenter(s):Christopher J. Kwolek, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | 15-Year Results Of EVAR 1 RCT Point The Way To A Clinical And Cost-Effective Benefit For EVAR |
|
Presenter(s):Roger M. Greenhalgh, MD Location: Grand Ballroom West, 3rd Floor |
|
| 7:32 AM - 7:37 AM | Long-Term Results Of The DREAM RCT Differ From Those Of EVAR 1: EVAR Is Therefore Superior To Open Repair: Why The Difference |
|
Presenter(s):Jan D. Blankensteijn, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:38 AM - 7:43 AM | There Are Flaws In Interpreting The EVAR 1 Long-Term Results To Show EVAR Is Not Superior To Open Repair: EVAR 1 15-Year Result Plus Other Data Show EVAR To Be Better Than Open Repair Short And Long-Term |
|
Presenter(s):Frank E.G. Vermassen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:44 AM - 7:49 AM | Why The Long-Term Data From The EVAR RCTs Comparing EVAR With Open Repair Are Negatively Biased Toward EVAR: EVAR Should Currently Be The First Option For Most AAA Patients |
|
Presenter(s):Vicente Riambau, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:50 AM - 7:55 AM | 15-Year Results Of EVAR With The Zenith Flex AAA Endograft Show Better EVAR Outcomes Than In The EVAR 1 Trial At All Time Points |
|
Presenter(s):Fabio Verzini, MD, PhD / Piergiorgio Cao, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:56 AM - 8:07 AM | Panel Discussion |
| END OF SESSION 9 | |
| previous | next |